Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Senseonics Holdings Inc's Business Segments
Senseonics Holdings Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of Q1 FY2026
Reportable Segments
1
Largest Segment
Single reportable segment
Total Revenue
$ 11
Regions Reported
-
Revenue Share by Reportable Segment - Q1 FY2026
- Single reportable segment0%
Revenue by Reportable Segment - Q1 FY2026
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Single reportable segment | $ 12 | - |
Description of Senseonics Holdings Inc
We are a medical technology firm focusing on the research and production of glucose monitoring solutions with distinctive, long-term implanted glucose management technologies to change lives in the worldwide diabetic community. Our Eversense, Eversense XL, and Eversense E3 continuous glucose monitoring (CGM) systems are designed to continuously and accurately measure glucose levels in people with diabetes using an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for up to six months, versus seven to 14 days for non-implantable CGM systems.
Senseonics Holdings Inc. is a medical technology company primarily focused on the development of innovative solutions for diabetes management. Their portfolio is centered around Continuous Glucose Monitoring (CGM) systems, which provide patients with diabetes with real-time glucose data. Below is an extensive description of the segments, products, and services offered by Senseonics.
Segments
1. Diabetes Management
- Primary Focus: Senseonics targets individuals with diabetes, particularly those requiring continuous monitoring for effective management of their condition.
- Market Opportunity: The growing prevalence of diabetes creates a significant opportunity for innovative monitoring solutions that enhance patient outcomes and provide more effective disease management.
2. Medical Devices
- Regulatory Compliance: All products are developed in accordance with strict regulatory guidelines to ensure safety and efficacy in medical use.
- Research and Development: Intense focus on R&D to enhance existing technologies and develop next-generation products.
Products
1. Eversense CGM System
- Overview: The Eversense system is a long-term implanted glucose monitoring device designed for adults with diabetes.
- Components:
- Sensor: A small sensor is inserted under the skin, where it can continuously measure glucose levels for an extended period, typically up to 90 days or more, depending on the version.
- Transmitter: A programmable transmitter is worn over the sensor site and transmits data wirelessly to a mobile application, providing real-time glucose readings and trends.
- Mobile Application: A user-friendly app that displays glucose levels, trends, and alerts for users and caregivers, ensuring a comprehensive view of glucose management.
- Extended Wear: One of the most significant advantages is that it allows for long-term use without the need for frequent sensor replacements, as is common with traditional CGM systems.
2. Eversense XL
- Overview: This is an enhanced version of the original Eversense system that offers an extended wear time of up to 180 days (subject to regulatory approvals). The XL system is designed for the same target demographic but aims to reduce the inconvenience of frequent sensor replacements.
- Features: Similar to the original Eversense but with improvements in sensor technology, providing more accurate readings and longer wearability.
3. Mobile Application Features
- Real-time Monitoring: Provides users with continuous access to their glucose data, enabling quicker responses to changes in glucose levels.
- Alerts and Notifications: Users can receive alerts for high or low glucose levels, helping to prevent hyperglycemic or hypoglycemic events.
- Data Sharing: The application often allows for sharing glucose data with healthcare providers and family members, fostering teamwork in diabetes management.
Services
1. Product Training and Support
- Professional Support: Senseonics typically offers training sessions for healthcare professionals to ensure they understand how to use and prescribe the Eversense system effectively.
- Patient Support: Users receive guidance on how to operate the device, interpret data, and understand the implications of their glucose levels.
2. Clinical Research and Studies
- Ongoing Research: Senseonics is involved in conducting clinical studies to gather data on the safety and efficacy of its products, which enhances its credibility and compliance with regulatory standards.
- Data Utilization: The company may publish results from these studies to inform the medical community and users about the capabilities of their products.
3. Partnerships and Collaborations
- Strategic Alliances: Senseonics often collaborates with healthcare providers, technology partners, and research institutions to foster innovation and improve healthcare delivery.
4. Regulatory Affairs Services
- Quality Assurance: Ensuring all devices meet the stringent requirements set by regulatory bodies, providing a comprehensive framework for quality services in the healthcare sector.
Conclusion
Senseonics focus on continuous glucose monitoring through its Eversense systems allows for a significant evolution in diabetes management. By providing advanced technologies that enhance the quality of life for diabetic patients and streamline the process of glucose monitoring, Senseonics positions itself as a leader in the field. Through persistent innovation, research, and an unwavering commitment to patient care, the company aims to meet the evolving needs of its users and healthcare providers alike.
Segments
1. Diabetes Management
- Primary Focus: Senseonics targets individuals with diabetes, particularly those requiring continuous monitoring for effective management of their condition.
- Market Opportunity: The growing prevalence of diabetes creates a significant opportunity for innovative monitoring solutions that enhance patient outcomes and provide more effective disease management.
2. Medical Devices
- Regulatory Compliance: All products are developed in accordance with strict regulatory guidelines to ensure safety and efficacy in medical use.
- Research and Development: Intense focus on R&D to enhance existing technologies and develop next-generation products.
Products
1. Eversense CGM System
- Overview: The Eversense system is a long-term implanted glucose monitoring device designed for adults with diabetes.
- Components:
- Sensor: A small sensor is inserted under the skin, where it can continuously measure glucose levels for an extended period, typically up to 90 days or more, depending on the version.
- Transmitter: A programmable transmitter is worn over the sensor site and transmits data wirelessly to a mobile application, providing real-time glucose readings and trends.
- Mobile Application: A user-friendly app that displays glucose levels, trends, and alerts for users and caregivers, ensuring a comprehensive view of glucose management.
- Extended Wear: One of the most significant advantages is that it allows for long-term use without the need for frequent sensor replacements, as is common with traditional CGM systems.
2. Eversense XL
- Overview: This is an enhanced version of the original Eversense system that offers an extended wear time of up to 180 days (subject to regulatory approvals). The XL system is designed for the same target demographic but aims to reduce the inconvenience of frequent sensor replacements.
- Features: Similar to the original Eversense but with improvements in sensor technology, providing more accurate readings and longer wearability.
3. Mobile Application Features
- Real-time Monitoring: Provides users with continuous access to their glucose data, enabling quicker responses to changes in glucose levels.
- Alerts and Notifications: Users can receive alerts for high or low glucose levels, helping to prevent hyperglycemic or hypoglycemic events.
- Data Sharing: The application often allows for sharing glucose data with healthcare providers and family members, fostering teamwork in diabetes management.
Services
1. Product Training and Support
- Professional Support: Senseonics typically offers training sessions for healthcare professionals to ensure they understand how to use and prescribe the Eversense system effectively.
- Patient Support: Users receive guidance on how to operate the device, interpret data, and understand the implications of their glucose levels.
2. Clinical Research and Studies
- Ongoing Research: Senseonics is involved in conducting clinical studies to gather data on the safety and efficacy of its products, which enhances its credibility and compliance with regulatory standards.
- Data Utilization: The company may publish results from these studies to inform the medical community and users about the capabilities of their products.
3. Partnerships and Collaborations
- Strategic Alliances: Senseonics often collaborates with healthcare providers, technology partners, and research institutions to foster innovation and improve healthcare delivery.
4. Regulatory Affairs Services
- Quality Assurance: Ensuring all devices meet the stringent requirements set by regulatory bodies, providing a comprehensive framework for quality services in the healthcare sector.
Conclusion
Senseonics focus on continuous glucose monitoring through its Eversense systems allows for a significant evolution in diabetes management. By providing advanced technologies that enhance the quality of life for diabetic patients and streamline the process of glucose monitoring, Senseonics positions itself as a leader in the field. Through persistent innovation, research, and an unwavering commitment to patient care, the company aims to meet the evolving needs of its users and healthcare providers alike.